Cargando…

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity

PURPOSE: Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) has been evaluated in several recent studies. The CyberKnife(®) is an SBRT system that allows for real-time tracking of the tumor. The purpose of this study was to evaluate the prognostic factors for local control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bibault, Jean-Emmanuel, Dewas, Sylvain, Vautravers-Dewas, Claire, Hollebecque, Antoine, Jarraya, Hajer, Lacornerie, Thomas, Lartigau, Eric, Mirabel, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795696/ https://www.ncbi.nlm.nih.gov/pubmed/24147002 http://dx.doi.org/10.1371/journal.pone.0077472

Ejemplares similares

Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy
por: Dewas, Sylvain, et al.
Publicado: (2012)

Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results
por: Dewas, Sylvain, et al.
Publicado: (2011)

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
por: Fumagalli, Ingrid, et al.
Publicado: (2012)

Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking
por: Jarraya, Hajer, et al.
Publicado: (2013)

Adjuvant radiation therapy in metastatic lymph nodes from melanoma
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2011)

Delineation in thoracic oncology: a prospective study of the effect of training on contour variability and dosimetric consequences
por: Dewas, Sylvain, et al.
Publicado: (2011)

Image-Guided Robotic Stereotactic Radiation Therapy with Fiducial-Free Tumor Tracking for Lung Cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2012)

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
por: Roquette, Isaure, et al.
Publicado: (2022)

Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
por: Dewas, Claire Vautravers, et al.
Publicado: (2012)

Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2015)

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome
por: Adenis, Antoine, et al.
Publicado: (2013)

Chest Magnetic Resonance Imaging Decreases Inter-observer Variability of Gross Target Volume for Lung Tumors
por: Basson, Laurent, et al.
Publicado: (2019)

GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms
por: Lacornerie, Thomas, et al.
Publicado: (2014)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
por: Scouarnec, Cyrielle, et al.
Publicado: (2019)

Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series
por: Fessart, Etienne, et al.
Publicado: (2020)

Feasibility Study of Pelvic Helical IMRT for Elderly Patients with Endometrial Cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2014)

Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy
por: Zaine, Hind, et al.
Publicado: (2021)

Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results
por: Olivier, Jonathan, et al.
Publicado: (2019)

Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy
por: Le Reun, Eymeric, et al.
Publicado: (2023)

Studies of Intra-Fraction Prostate Motion During Stereotactic Irradiation in First Irradiation and Re-Irradiation
por: Taillez, Alexandre, et al.
Publicado: (2021)

Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control
por: Meniai-Merzouki, F., et al.
Publicado: (2018)

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)
por: Pasquier, David, et al.
Publicado: (2017)

Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
por: Liang, Ping, et al.
Publicado: (2016)

Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life
por: Pasquier, David, et al.
Publicado: (2019)

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial
por: Pasquier, David, et al.
Publicado: (2023)

Defining Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated with Stereotactic Body Radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2017)

Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer
por: Vaugier, Loïg, et al.
Publicado: (2021)

The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
por: Waters, Michael R, et al.
Publicado: (2023)

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases
por: Martinage, Geoffrey, et al.
Publicado: (2019)

Major impact of COVID-19 national containment on activities in the French northern comprehensive cancer center
por: Penel, Nicolas, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey
por: Vilotte, F., et al.
Publicado: (2022)

Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity
por: Toesca, Diego A.S., et al.
Publicado: (2018)

Social media for radiation oncologists: A practical primer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2017)

Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration
por: Lee, Sumin, et al.
Publicado: (2018)

BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol
por: Pasquier, David, et al.
Publicado: (2018)

Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center
por: Leroy, Thomas, et al.
Publicado: (2017)

Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
por: Yoon, Sang Min, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies
por: Schaub, Stephanie K., et al.
Publicado: (2018)

Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ui1fvjcducu1huomp1ifuo5kn4